Article Text
Education in Heart
Acute cardiovascular care
Troponins: established and novel indications in the management of cardiovascular disease
Statistics from Altmetric.com
Footnotes
Contributors EG and HAK contributed equally for concept and draft.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests HAK received honoraria from Bayer Vital, Roche Diagnostics, Daiichi Sankyo. EG received honoraria from Bayer Vital, AstraZeneca, Roche Diagnostics, BRAHMS Germany, MSD Deutschland, Daiichi Sankyo.
Patient consent Not required.
Provenance and peer review Commissioned; externally peer reviewed.
Author note References that include a * have been selected as key references for this paper.